Equine Pharmaceuticals and Supplements Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Equine Pharmaceuticals and Supplements market size was valued at USD 1181.2 million in 2022 and is forecast to a readjusted size of USD 1586.8 million by 2029 with a CAGR of 4.3% during review period.

Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.

Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%. North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent. In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.

This report is a detailed and comprehensive analysis for global Equine Pharmaceuticals and Supplements market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Equine Pharmaceuticals and Supplements market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Equine Pharmaceuticals and Supplements market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Equine Pharmaceuticals and Supplements market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Equine Pharmaceuticals and Supplements market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Equine Pharmaceuticals and Supplements
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Equine Pharmaceuticals and Supplements market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Boehringer Ingelheim
   Merck Animal Health
   Zoetis
   Bayer Animal Health
   Elanco Animal Health
   Dechra Veterinary Products
   CEVA
   Virbac
   Norbrook Equine
   Kyoritsu Seiyaku
   Vetoquinol
   Protexin Healthcare
   Audevard
   Ouro Fino Saude

   Pharmaceuticals
   Supplements

   Thoroughbred Horse
   Other Types of Horses

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Equine Pharmaceuticals and Supplements Market in 2025?

The market benefits from a growing awareness of equine health and wellness among horse owners, leading to increased demand for specialized pharmaceuticals and supplements. Additionally, advancements in veterinary science and technology enhance product efficacy and safety, attracting more consumers.

What are the weaknesses of the Equine Pharmaceuticals and Supplements Market in 2025?

High product costs can limit accessibility for some horse owners, particularly in developing regions. Furthermore, the market may face challenges related to regulatory compliance and the need for extensive research to support product claims, which can slow down innovation.

What opportunities exist for the Equine Pharmaceuticals and Supplements Market in 2025?

There is potential for growth in emerging markets where equestrian activities are becoming more popular. Furthermore, the rise of online retail channels offers an opportunity for companies to reach a broader audience and improve customer engagement through targeted marketing strategies.

What threats could impact the Equine Pharmaceuticals and Supplements Market in 2025?

The market may face increased competition from generic products, which could drive prices down and affect profit margins. Additionally, economic downturns or changes in consumer spending habits may lead to reduced expenditures on non-essential equine products, impacting overall sales.

What are the political factors affecting the Equine Pharmaceuticals and Supplements Market in 2025?

Government regulations regarding veterinary products and their safety standards can influence the approval and marketing of equine pharmaceuticals. Changes in policies related to animal welfare and agriculture may also impact the availability of raw materials or product formulations.

What economic factors are influencing the Equine Pharmaceuticals and Supplements Market in 2025?

Economic conditions such as consumer disposable income and spending patterns on non-essential items will affect market growth. Additionally, fluctuations in the cost of raw materials and labor, along with the affordability of equine healthcare products, may determine the price points and demand.

What social factors are relevant to the Equine Pharmaceuticals and Supplements Market in 2025?

Growing awareness among horse owners about the importance of equine health and wellness drives demand for specialized products. The increasing trend of treating horses as family pets, alongside rising participation in equestrian sports, contributes to a greater focus on health supplements and medical products.

What technological factors are impacting the Equine Pharmaceuticals and Supplements Market in 2025?

Advances in veterinary medicine and biotechnology play a crucial role in enhancing the effectiveness and safety of equine pharmaceuticals. The development of new drug delivery systems, as well as the use of digital platforms for consumer education and product distribution, offers market opportunities.

What environmental factors affect the Equine Pharmaceuticals and Supplements Market in 2025?

Sustainability concerns regarding the sourcing of raw materials, packaging waste, and the environmental impact of pharmaceutical production can influence brand choices and consumer perceptions. Regulations concerning eco-friendly practices may encourage companies to adopt greener approaches to product development and packaging.

What legal factors are relevant to the Equine Pharmaceuticals and Supplements Market in 2025?

Strict regulatory frameworks regarding product safety, labeling, and advertising, as well as intellectual property rights, can impact the market. Legal considerations regarding the import/export of veterinary products, along with potential lawsuits related to product efficacy or side effects, may pose challenges.

Who are the suppliers in the Equine Pharmaceuticals and Supplements Market in 2025?

Suppliers include manufacturers of active pharmaceutical ingredients (APIs), raw materials for supplements, packaging providers, and specialized veterinary ingredient producers. Regulatory bodies also play a role as suppliers by setting standards that guide production and distribution processes.

Who are the customers in the Equine Pharmaceuticals and Supplements Market in 2025?

Customers include horse owners, equine veterinarians, equestrian sports organizations, pet care professionals, and veterinary clinics. Additionally, online retailers and distribution channels cater to individual horse owners and larger institutions with equine health needs.

What are the key inputs in the Equine Pharmaceuticals and Supplements Market in 2025?

Key inputs include raw materials for pharmaceuticals and supplements, scientific research for product development, veterinary expertise, regulatory knowledge, and technology for product formulation and delivery. Also, data from consumer trends and market research are vital for creating targeted products.

What are the main processes in the Equine Pharmaceuticals and Supplements Market in 2025?

Main processes involve research and development (R&D) of new products, clinical trials to test efficacy and safety, manufacturing of the final products, packaging, and distribution through various channels such as veterinary clinics, online platforms, and retail stores. Marketing and customer education are also crucial.

What are the outputs of the Equine Pharmaceuticals and Supplements Market in 2025?

Outputs include a range of pharmaceutical products like anti-inflammatory medications, joint health supplements, and vitamins for horses. Other outputs include customer feedback, market reports, and enhanced formulations based on consumer and veterinary needs.

What is the threat of new entrants in the Equine Pharmaceuticals and Supplements Market in 2025?

The threat of new entrants is moderate. While the market offers growth opportunities, high regulatory barriers, significant research and development costs, and the need for specialized knowledge can deter new companies from entering. Established brands also enjoy strong customer loyalty.

What is the bargaining power of suppliers in the Equine Pharmaceuticals and Supplements Market in 2025?

Suppliers have moderate bargaining power. While there are numerous suppliers for raw materials and ingredients, some specialized components required for high-quality equine products may be limited, giving certain suppliers more leverage in negotiations.

What is the bargaining power of buyers in the Equine Pharmaceuticals and Supplements Market in 2025?

Buyers have moderate bargaining power. Horse owners and veterinarians have access to a variety of products, allowing them to compare prices and quality. However, brand loyalty and trust in product efficacy reduce their bargaining power in some cases.

What is the threat of substitute products in the Equine Pharmaceuticals and Supplements Market in 2025?

The threat of substitutes is low to moderate. While alternative natural remedies and generic products exist, the specialized nature of pharmaceuticals and supplements for equines makes it difficult for substitutes to offer the same level of effectiveness or safety as branded products.

What is the intensity of competitive rivalry in the Equine Pharmaceuticals and Supplements Market in 2025?

The competitive rivalry is high. The market has several established players offering a variety of products. Companies are constantly innovating to differentiate themselves through product quality, efficacy, and pricing, leading to strong competition for market share.

What are the key raw materials and inputs in the Equine Pharmaceuticals and Supplements Market in 2025?

Key raw materials include active pharmaceutical ingredients (APIs) such as anti-inflammatory compounds, vitamins, and joint supplements, as well as excipients for formulation. Natural ingredients such as herbs, minerals, and proteins are also important for the production of supplements.

What suppliers are critical to the Equine Pharmaceuticals and Supplements Market in 2025?

Critical suppliers include manufacturers of APIs, specialized producers of equine-specific ingredients, and companies providing packaging materials. Veterinary consultants and regulatory bodies that enforce safety and efficacy standards also play a significant role in the upstream supply chain.

What are the challenges faced by suppliers in the Equine Pharmaceuticals and Supplements Market in 2025?

Suppliers face challenges like fluctuating raw material costs, stringent regulatory requirements, and the need for high-quality production standards. Sourcing specialty ingredients in a sustainable and cost-effective manner can also pose difficulties, particularly with increasing demand for natural and organic products.

What role does technology play in the upstream process of the Equine Pharmaceuticals and Supplements Market in 2025?

Technology plays a vital role in improving the efficiency and safety of production processes. Advancements in biotechnology enable the development of more effective supplements, while automation in manufacturing and packaging reduces costs and increases scalability. Research and development technologies also contribute to the continuous improvement of formulations.

What are the key risks in the upstream supply chain of the Equine Pharmaceuticals and Supplements Market in 2025?

Key risks include supply chain disruptions due to geopolitical issues, environmental challenges affecting the availability of natural ingredients, and changes in regulatory standards. Additionally, the increasing pressure to meet sustainability goals may impact sourcing practices and manufacturing processes.

What are the key processes in the midstream of the Equine Pharmaceuticals and Supplements Market in 2025?

The key processes include product formulation, clinical testing, and regulatory approval. Manufacturers also focus on quality control, ensuring products meet safety and efficacy standards. Packaging, labeling, and compliance with veterinary regulations are important steps before the product reaches distribution.

What role does manufacturing play in the midstream of the Equine Pharmaceuticals and Supplements Market in 2025?

Manufacturing is critical for the production of high-quality pharmaceuticals and supplements. It involves blending, compounding, and ensuring the right formulation of active ingredients. The manufacturing process must adhere to stringent guidelines set by regulatory bodies, maintaining product consistency and safety.

What challenges do manufacturers face in the midstream of the Equine Pharmaceuticals and Supplements Market in 2025?

Manufacturers face challenges such as maintaining product quality amidst increasing demand, ensuring compliance with evolving regulations, and managing production costs. Sourcing specialized ingredients for unique formulations and addressing potential supply chain disruptions also present difficulties.

What role do regulatory bodies play in the midstream of the Equine Pharmaceuticals and Supplements Market in 2025?

Regulatory bodies ensure that equine pharmaceuticals and supplements meet required safety, quality, and efficacy standards. They enforce compliance with labeling, packaging, and marketing guidelines and may conduct inspections to ensure manufacturers adhere to good manufacturing practices.

How does technology impact the midstream process of the Equine Pharmaceuticals and Supplements Market in 2025?

Technology impacts the midstream by streamlining the manufacturing process through automation, improving precision in formulations, and enhancing testing protocols. Advanced technologies such as data analytics and artificial intelligence help with predictive quality control, reducing errors and increasing efficiency in production.

What are the key distribution channels in the downstream of the Equine Pharmaceuticals and Supplements Market in 2025?

Key distribution channels include veterinary clinics, online retail platforms, equine health stores, and direct sales through manufacturers. E-commerce platforms are becoming increasingly popular due to their convenience, offering easy access to a wide range of products for horse owners.

What are the challenges in the downstream segment of the Equine Pharmaceuticals and Supplements Market in 2025?

Challenges in the downstream segment include ensuring consistent product availability across various distribution channels and managing the logistics of cold chain products or sensitive supplements. Additionally, educating consumers about the benefits and correct usage of the products remains a crucial task for distributors.

How do consumers access products in the downstream of the Equine Pharmaceuticals and Supplements Market in 2025?

Consumers typically access products through direct purchases from veterinary practices, specialized equine retailers, and online marketplaces. Increasingly, online platforms are becoming a primary channel for product education, reviews, and purchase, allowing customers to select tailored products for their horses.

What role does marketing play in the downstream of the Equine Pharmaceuticals and Supplements Market in 2025?

Marketing plays a vital role in educating consumers about the benefits of specific pharmaceuticals and supplements for horses. It also helps build brand loyalty and trust. Companies use digital marketing, partnerships with equine professionals, and targeted campaigns to reach their audience effectively.

What are the emerging trends in the downstream segment of the Equine Pharmaceuticals and Supplements Market in 2025?

Emerging trends include the growing preference for natural and organic supplements, increased use of telemedicine in veterinary care, and the shift toward personalized health solutions for horses. Additionally, the rise of subscription-based models for regular delivery of equine health products is gaining popularity.

Chapter 1, to describe Equine Pharmaceuticals and Supplements product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Pharmaceuticals and Supplements, with price, sales, revenue and global market share of Equine Pharmaceuticals and Supplements from 2018 to 2023.
Chapter 3, the Equine Pharmaceuticals and Supplements competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Pharmaceuticals and Supplements breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Pharmaceuticals and Supplements.
Chapter 14 and 15, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Equine Pharmaceuticals and Supplements
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Equine Pharmaceuticals and Supplements Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Pharmaceuticals
       1.3.3 Supplements
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Equine Pharmaceuticals and Supplements Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Thoroughbred Horse
       1.4.3 Other Types of Horses
   1.5 Global Equine Pharmaceuticals and Supplements Market Size & Forecast
       1.5.1 Global Equine Pharmaceuticals and Supplements Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Equine Pharmaceuticals and Supplements Sales Quantity (2018-2029)
       1.5.3 Global Equine Pharmaceuticals and Supplements Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Boehringer Ingelheim
       2.1.1 Boehringer Ingelheim Details
       2.1.2 Boehringer Ingelheim Major Business
       2.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
       2.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Boehringer Ingelheim Recent Developments/Updates
   2.2 Merck Animal Health
       2.2.1 Merck Animal Health Details
       2.2.2 Merck Animal Health Major Business
       2.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
       2.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Merck Animal Health Recent Developments/Updates
   2.3 Zoetis
       2.3.1 Zoetis Details
       2.3.2 Zoetis Major Business
       2.3.3 Zoetis Equine Pharmaceuticals and Supplements Product and Services
       2.3.4 Zoetis Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Zoetis Recent Developments/Updates
   2.4 Bayer Animal Health
       2.4.1 Bayer Animal Health Details
       2.4.2 Bayer Animal Health Major Business
       2.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
       2.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Bayer Animal Health Recent Developments/Updates
   2.5 Elanco Animal Health
       2.5.1 Elanco Animal Health Details
       2.5.2 Elanco Animal Health Major Business
       2.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
       2.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Elanco Animal Health Recent Developments/Updates
   2.6 Dechra Veterinary Products
       2.6.1 Dechra Veterinary Products Details
       2.6.2 Dechra Veterinary Products Major Business
       2.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
       2.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Dechra Veterinary Products Recent Developments/Updates
   2.7 CEVA
       2.7.1 CEVA Details
       2.7.2 CEVA Major Business
       2.7.3 CEVA Equine Pharmaceuticals and Supplements Product and Services
       2.7.4 CEVA Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 CEVA Recent Developments/Updates
   2.8 Virbac
       2.8.1 Virbac Details
       2.8.2 Virbac Major Business
       2.8.3 Virbac Equine Pharmaceuticals and Supplements Product and Services
       2.8.4 Virbac Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Virbac Recent Developments/Updates
   2.9 Norbrook Equine
       2.9.1 Norbrook Equine Details
       2.9.2 Norbrook Equine Major Business
       2.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
       2.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Norbrook Equine Recent Developments/Updates
   2.10 Kyoritsu Seiyaku
       2.10.1 Kyoritsu Seiyaku Details
       2.10.2 Kyoritsu Seiyaku Major Business
       2.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
       2.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Kyoritsu Seiyaku Recent Developments/Updates
   2.11 Vetoquinol
       2.11.1 Vetoquinol Details
       2.11.2 Vetoquinol Major Business
       2.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
       2.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Vetoquinol Recent Developments/Updates
   2.12 Protexin Healthcare
       2.12.1 Protexin Healthcare Details
       2.12.2 Protexin Healthcare Major Business
       2.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
       2.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Protexin Healthcare Recent Developments/Updates
   2.13 Audevard
       2.13.1 Audevard Details
       2.13.2 Audevard Major Business
       2.13.3 Audevard Equine Pharmaceuticals and Supplements Product and Services
       2.13.4 Audevard Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 Audevard Recent Developments/Updates
   2.14 Ouro Fino Saude
       2.14.1 Ouro Fino Saude Details
       2.14.2 Ouro Fino Saude Major Business
       2.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
       2.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 Ouro Fino Saude Recent Developments/Updates

3 Competitive Environment: Equine Pharmaceuticals and Supplements by Manufacturer

   3.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2018-2023)
   3.3 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Equine Pharmaceuticals and Supplements by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2022
       3.4.2 Top 6 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2022
   3.5 Equine Pharmaceuticals and Supplements Market: Overall Company Footprint Analysis
       3.5.1 Equine Pharmaceuticals and Supplements Market: Region Footprint
       3.5.2 Equine Pharmaceuticals and Supplements Market: Company Product Type Footprint
       3.5.3 Equine Pharmaceuticals and Supplements Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Equine Pharmaceuticals and Supplements Market Size by Region
       4.1.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2029)
       4.1.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2029)
       4.1.3 Global Equine Pharmaceuticals and Supplements Average Price by Region (2018-2029)
   4.2 North America Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)
   4.3 Europe Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)
   4.4 Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)
   4.5 South America Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)
   4.6 Middle East and Africa Equine Pharmaceuticals and Supplements Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
   5.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Type (2018-2029)
   5.3 Global Equine Pharmaceuticals and Supplements Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
   6.2 Global Equine Pharmaceuticals and Supplements Consumption Value by Application (2018-2029)
   6.3 Global Equine Pharmaceuticals and Supplements Average Price by Application (2018-2029)

7 North America

   7.1 North America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
   7.2 North America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
   7.3 North America Equine Pharmaceuticals and Supplements Market Size by Country
       7.3.1 North America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2029)
       7.3.2 North America Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
   8.2 Europe Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
   8.3 Europe Equine Pharmaceuticals and Supplements Market Size by Country
       8.3.1 Europe Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2029)
       8.3.2 Europe Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size by Region
       9.3.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
   10.2 South America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
   10.3 South America Equine Pharmaceuticals and Supplements Market Size by Country
       10.3.1 South America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2029)
       10.3.2 South America Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Equine Pharmaceuticals and Supplements Market Size by Country
       11.3.1 Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Equine Pharmaceuticals and Supplements Market Drivers
   12.2 Equine Pharmaceuticals and Supplements Market Restraints
   12.3 Equine Pharmaceuticals and Supplements Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Equine Pharmaceuticals and Supplements and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Equine Pharmaceuticals and Supplements
   13.3 Equine Pharmaceuticals and Supplements Production Process
   13.4 Equine Pharmaceuticals and Supplements Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Equine Pharmaceuticals and Supplements Typical Distributors
   14.3 Equine Pharmaceuticals and Supplements Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Equine Pharmaceuticals and Supplements Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Equine Pharmaceuticals and Supplements Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
   Table 4. Boehringer Ingelheim Major Business
   Table 5. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product and Services
   Table 6. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Boehringer Ingelheim Recent Developments/Updates
   Table 8. Merck Animal Health Basic Information, Manufacturing Base and Competitors
   Table 9. Merck Animal Health Major Business
   Table 10. Merck Animal Health Equine Pharmaceuticals and Supplements Product and Services
   Table 11. Merck Animal Health Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Merck Animal Health Recent Developments/Updates
   Table 13. Zoetis Basic Information, Manufacturing Base and Competitors
   Table 14. Zoetis Major Business
   Table 15. Zoetis Equine Pharmaceuticals and Supplements Product and Services
   Table 16. Zoetis Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Zoetis Recent Developments/Updates
   Table 18. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
   Table 19. Bayer Animal Health Major Business
   Table 20. Bayer Animal Health Equine Pharmaceuticals and Supplements Product and Services
   Table 21. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Bayer Animal Health Recent Developments/Updates
   Table 23. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
   Table 24. Elanco Animal Health Major Business
   Table 25. Elanco Animal Health Equine Pharmaceuticals and Supplements Product and Services
   Table 26. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Elanco Animal Health Recent Developments/Updates
   Table 28. Dechra Veterinary Products Basic Information, Manufacturing Base and Competitors
   Table 29. Dechra Veterinary Products Major Business
   Table 30. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product and Services
   Table 31. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Dechra Veterinary Products Recent Developments/Updates
   Table 33. CEVA Basic Information, Manufacturing Base and Competitors
   Table 34. CEVA Major Business
   Table 35. CEVA Equine Pharmaceuticals and Supplements Product and Services
   Table 36. CEVA Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. CEVA Recent Developments/Updates
   Table 38. Virbac Basic Information, Manufacturing Base and Competitors
   Table 39. Virbac Major Business
   Table 40. Virbac Equine Pharmaceuticals and Supplements Product and Services
   Table 41. Virbac Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Virbac Recent Developments/Updates
   Table 43. Norbrook Equine Basic Information, Manufacturing Base and Competitors
   Table 44. Norbrook Equine Major Business
   Table 45. Norbrook Equine Equine Pharmaceuticals and Supplements Product and Services
   Table 46. Norbrook Equine Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Norbrook Equine Recent Developments/Updates
   Table 48. Kyoritsu Seiyaku Basic Information, Manufacturing Base and Competitors
   Table 49. Kyoritsu Seiyaku Major Business
   Table 50. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product and Services
   Table 51. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. Kyoritsu Seiyaku Recent Developments/Updates
   Table 53. Vetoquinol Basic Information, Manufacturing Base and Competitors
   Table 54. Vetoquinol Major Business
   Table 55. Vetoquinol Equine Pharmaceuticals and Supplements Product and Services
   Table 56. Vetoquinol Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Vetoquinol Recent Developments/Updates
   Table 58. Protexin Healthcare Basic Information, Manufacturing Base and Competitors
   Table 59. Protexin Healthcare Major Business
   Table 60. Protexin Healthcare Equine Pharmaceuticals and Supplements Product and Services
   Table 61. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 62. Protexin Healthcare Recent Developments/Updates
   Table 63. Audevard Basic Information, Manufacturing Base and Competitors
   Table 64. Audevard Major Business
   Table 65. Audevard Equine Pharmaceuticals and Supplements Product and Services
   Table 66. Audevard Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 67. Audevard Recent Developments/Updates
   Table 68. Ouro Fino Saude Basic Information, Manufacturing Base and Competitors
   Table 69. Ouro Fino Saude Major Business
   Table 70. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product and Services
   Table 71. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 72. Ouro Fino Saude Recent Developments/Updates
   Table 73. Global Equine Pharmaceuticals and Supplements Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 74. Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 75. Global Equine Pharmaceuticals and Supplements Average Price by Manufacturer (2018-2023) & (USD/Unit)
   Table 76. Market Position of Manufacturers in Equine Pharmaceuticals and Supplements, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 77. Head Office and Equine Pharmaceuticals and Supplements Production Site of Key Manufacturer
   Table 78. Equine Pharmaceuticals and Supplements Market: Company Product Type Footprint
   Table 79. Equine Pharmaceuticals and Supplements Market: Company Product Application Footprint
   Table 80. Equine Pharmaceuticals and Supplements New Market Entrants and Barriers to Market Entry
   Table 81. Equine Pharmaceuticals and Supplements Mergers, Acquisition, Agreements, and Collaborations
   Table 82. Global Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2023) & (K Units)
   Table 83. Global Equine Pharmaceuticals and Supplements Sales Quantity by Region (2024-2029) & (K Units)
   Table 84. Global Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2023) & (USD Million)
   Table 85. Global Equine Pharmaceuticals and Supplements Consumption Value by Region (2024-2029) & (USD Million)
   Table 86. Global Equine Pharmaceuticals and Supplements Average Price by Region (2018-2023) & (USD/Unit)
   Table 87. Global Equine Pharmaceuticals and Supplements Average Price by Region (2024-2029) & (USD/Unit)
   Table 88. Global Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
   Table 89. Global Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
   Table 90. Global Equine Pharmaceuticals and Supplements Consumption Value by Type (2018-2023) & (USD Million)
   Table 91. Global Equine Pharmaceuticals and Supplements Consumption Value by Type (2024-2029) & (USD Million)
   Table 92. Global Equine Pharmaceuticals and Supplements Average Price by Type (2018-2023) & (USD/Unit)
   Table 93. Global Equine Pharmaceuticals and Supplements Average Price by Type (2024-2029) & (USD/Unit)
   Table 94. Global Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
   Table 95. Global Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
   Table 96. Global Equine Pharmaceuticals and Supplements Consumption Value by Application (2018-2023) & (USD Million)
   Table 97. Global Equine Pharmaceuticals and Supplements Consumption Value by Application (2024-2029) & (USD Million)
   Table 98. Global Equine Pharmaceuticals and Supplements Average Price by Application (2018-2023) & (USD/Unit)
   Table 99. Global Equine Pharmaceuticals and Supplements Average Price by Application (2024-2029) & (USD/Unit)
   Table 100. North America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
   Table 101. North America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
   Table 102. North America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
   Table 103. North America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
   Table 104. North America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2023) & (K Units)
   Table 105. North America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2024-2029) & (K Units)
   Table 106. North America Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2023) & (USD Million)
   Table 107. North America Equine Pharmaceuticals and Supplements Consumption Value by Country (2024-2029) & (USD Million)
   Table 108. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
   Table 109. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
   Table 110. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
   Table 111. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
   Table 112. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2023) & (K Units)
   Table 113. Europe Equine Pharmaceuticals and Supplements Sales Quantity by Country (2024-2029) & (K Units)
   Table 114. Europe Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2023) & (USD Million)
   Table 115. Europe Equine Pharmaceuticals and Supplements Consumption Value by Country (2024-2029) & (USD Million)
   Table 116. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
   Table 117. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
   Table 118. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
   Table 119. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
   Table 120. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2023) & (K Units)
   Table 121. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity by Region (2024-2029) & (K Units)
   Table 122. Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2023) & (USD Million)
   Table 123. Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value by Region (2024-2029) & (USD Million)
   Table 124. South America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
   Table 125. South America Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
   Table 126. South America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
   Table 127. South America Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
   Table 128. South America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2018-2023) & (K Units)
   Table 129. South America Equine Pharmaceuticals and Supplements Sales Quantity by Country (2024-2029) & (K Units)
   Table 130. South America Equine Pharmaceuticals and Supplements Consumption Value by Country (2018-2023) & (USD Million)
   Table 131. South America Equine Pharmaceuticals and Supplements Consumption Value by Country (2024-2029) & (USD Million)
   Table 132. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Type (2018-2023) & (K Units)
   Table 133. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Type (2024-2029) & (K Units)
   Table 134. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Application (2018-2023) & (K Units)
   Table 135. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Application (2024-2029) & (K Units)
   Table 136. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Region (2018-2023) & (K Units)
   Table 137. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity by Region (2024-2029) & (K Units)
   Table 138. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value by Region (2018-2023) & (USD Million)
   Table 139. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value by Region (2024-2029) & (USD Million)
   Table 140. Equine Pharmaceuticals and Supplements Raw Material
   Table 141. Key Manufacturers of Equine Pharmaceuticals and Supplements Raw Materials
   Table 142. Equine Pharmaceuticals and Supplements Typical Distributors
   Table 143. Equine Pharmaceuticals and Supplements Typical Customers

List of Figures

   Figure 1. Equine Pharmaceuticals and Supplements Picture
   Figure 2. Global Equine Pharmaceuticals and Supplements Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Type in 2022
   Figure 4. Pharmaceuticals Examples
   Figure 5. Supplements Examples
   Figure 6. Global Equine Pharmaceuticals and Supplements Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 7. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Application in 2022
   Figure 8. Thoroughbred Horse Examples
   Figure 9. Other Types of Horses Examples
   Figure 10. Global Equine Pharmaceuticals and Supplements Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 11. Global Equine Pharmaceuticals and Supplements Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 12. Global Equine Pharmaceuticals and Supplements Sales Quantity (2018-2029) & (K Units)
   Figure 13. Global Equine Pharmaceuticals and Supplements Average Price (2018-2029) & (USD/Unit)
   Figure 14. Global Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Manufacturer in 2022
   Figure 15. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Manufacturer in 2022
   Figure 16. Producer Shipments of Equine Pharmaceuticals and Supplements by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 17. Top 3 Equine Pharmaceuticals and Supplements Manufacturer (Consumption Value) Market Share in 2022
   Figure 18. Top 6 Equine Pharmaceuticals and Supplements Manufacturer (Consumption Value) Market Share in 2022
   Figure 19. Global Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Region (2018-2029)
   Figure 20. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Region (2018-2029)
   Figure 21. North America Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
   Figure 22. Europe Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
   Figure 23. Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
   Figure 24. South America Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
   Figure 25. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value (2018-2029) & (USD Million)
   Figure 26. Global Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
   Figure 27. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Type (2018-2029)
   Figure 28. Global Equine Pharmaceuticals and Supplements Average Price by Type (2018-2029) & (USD/Unit)
   Figure 29. Global Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
   Figure 30. Global Equine Pharmaceuticals and Supplements Consumption Value Market Share by Application (2018-2029)
   Figure 31. Global Equine Pharmaceuticals and Supplements Average Price by Application (2018-2029) & (USD/Unit)
   Figure 32. North America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
   Figure 33. North America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
   Figure 34. North America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Country (2018-2029)
   Figure 35. North America Equine Pharmaceuticals and Supplements Consumption Value Market Share by Country (2018-2029)
   Figure 36. United States Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 37. Canada Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 38. Mexico Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Europe Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
   Figure 40. Europe Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
   Figure 41. Europe Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Country (2018-2029)
   Figure 42. Europe Equine Pharmaceuticals and Supplements Consumption Value Market Share by Country (2018-2029)
   Figure 43. Germany Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 44. France Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 45. United Kingdom Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. Russia Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. Italy Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
   Figure 49. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
   Figure 50. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Region (2018-2029)
   Figure 51. Asia-Pacific Equine Pharmaceuticals and Supplements Consumption Value Market Share by Region (2018-2029)
   Figure 52. China Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 53. Japan Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 54. Korea Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. India Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Southeast Asia Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Australia Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. South America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
   Figure 59. South America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
   Figure 60. South America Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Country (2018-2029)
   Figure 61. South America Equine Pharmaceuticals and Supplements Consumption Value Market Share by Country (2018-2029)
   Figure 62. Brazil Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 63. Argentina Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 64. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Type (2018-2029)
   Figure 65. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Application (2018-2029)
   Figure 66. Middle East & Africa Equine Pharmaceuticals and Supplements Sales Quantity Market Share by Region (2018-2029)
   Figure 67. Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Value Market Share by Region (2018-2029)
   Figure 68. Turkey Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 69. Egypt Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 70. Saudi Arabia Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. South Africa Equine Pharmaceuticals and Supplements Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Equine Pharmaceuticals and Supplements Market Drivers
   Figure 73. Equine Pharmaceuticals and Supplements Market Restraints
   Figure 74. Equine Pharmaceuticals and Supplements Market Trends
   Figure 75. Porters Five Forces Analysis
   Figure 76. Manufacturing Cost Structure Analysis of Equine Pharmaceuticals and Supplements in 2022
   Figure 77. Manufacturing Process Analysis of Equine Pharmaceuticals and Supplements
   Figure 78. Equine Pharmaceuticals and Supplements Industrial Chain
   Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 80. Direct Channel Pros & Cons
   Figure 81. Indirect Channel Pros & Cons
   Figure 82. Methodology
   Figure 83. Research Process and Data Source